Skip to main content

Table 1 Cohort clinical and demographic data

From: Acute fibrinous and organising pneumonia following lung transplantation is associated with severe allograft dysfunction and poor outcome: a case series

Case

Age (years)

Gender

Transplant indication and type

Time to onset (days post-transplantation)

Diagnostic modality

Pulmonary functiona

Treatment

Other complications

Post-transplantation survival (days)

      

FEV1

FVC

   

1

49

Female

CHD with severe PH; HLT

58

TBB

na

na

Antibacterials Corticosteroids

Grade A1B0 acute rejection; Citrobacter freundii isolated from blood, BAL and urine

118

2

26

Male

CF; BLT

299

SLB

54%

79%

Antibacterials Corticosteroids

Candida albicans and Stenotrophomonas maltophilia isolated from blood; MSSA and mucoid Pseudomonas aeruginosa isolated from BAL

344

3

41

Female

Fibrotic NSIP; SLT (left)

56

TBB autopsy

97%

88%

Antibacterials Corticosteroids

Persistent poor graft function from the time of transplant; Grade A2B0 acute rejection (previous TBB)

278

4

34

Female

Bleomycin-related PF; BLT

2,572

TBB

70%

72%

Corticosteroids Antibacterials

Multi-drug-resistant S. maltophilia isolated from BAL; breast carcinoma metastatic to lungs

2,793

5

71

Female

IPF; SLT (right)

1,354

TBB

63%

74%

Corticosteroids Antibacterials

Onset preceded by symptomatic GER episode

1,514

6

23

Male

CF; BLT

804

TBB

49%

49%

Corticosteroids Antibacterials

URI symptoms and dyspnoea noted for 4 weeks prior to diagnosis

1,476

  1. BAL, bronchoalveolar lavage; BLT, bilateral lung transplant; CF, cystic fibrosis; CHD, congenital heart disease; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; HLT, heart-lung transplant; IPF, idiopathic pulmonary fibrosis; MSSA, methicillin-sensitive Staphylococcus aureus; na, not able to perform; NSIP, non-specific interstitial pneumonia; PF, pulmonary fibrosis; PH, pulmonary hypertension; SLB, surgical lung biopsy; SLT, single lung transplant; TBB, transbronchial lung biopsy; URI, upper respiratory infection; GER, gastro-oesophageal reflux
  2. apercentage of stable baseline values (average of 2 best results prior to acute fibrinous and organising pneumonia [AFOP] onset) at time of AFOP diagnosis